Clinical studies recruiting near Dresden

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migra
Phase 2 · Universitätsklinikum Carl Gustav Carus Dresden · AbbVie · NCT06602479 Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753 A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Universitaetsklinikum Carl Gustav Carus, Technischen Univers · Eli Lilly and Company · NCT07218380 Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05755386 Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · Universitaetsklinikum Carl Gustav Carus Dresden an der Techn · Princess Maxima Center for Pediatric Oncology · NCT05327894 A PMCF Study Confirm the Performance and Safety of the TufTex Over-the-Wire (OTW) Embolectomy Catheters
NA · University Hospital Carl Gustav Carus TU Dresden · LeMaitre Vascular · NCT05386342 A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes
Phase 3 · Dresden Center for Islet Transplantation · Vertex Pharmaceuticals Incorporated · NCT04786262 Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer
Phase 3 · Universitätsklinikum Carl Gustav Carus Dresden · AGO Study Group · NCT05009082 A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have P
Phase 2 · Universitaetsklinikum Carl Gustav Carus, Technischen Univers · Pfizer · NCT07073820 A Non-interventional, Prospective Study With Benralizumab
Phase N/A · Research Site · AstraZeneca · NCT06422078 REscue Stenting With CREDO® Heal for Recanalisation After Unsuccessful Thrombectomy (RECHRUT)
Phase N/A · Institut und Poliklinik für Diagnostische und Interventionel · Acandis GmbH · NCT05345483 Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
NA · Universitätsklinikum Carl Gustav Carus · Ad scientiam · NCT05566769 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Technische Universität Dresden - Medizinische Fakultät Carl · Hoffmann-La Roche · NCT06793215 Role of Pavlovian Mechanisms for Control Over Substance Use
Phase N/A · Department of Psychiatry and Psychotherapy, Technische Unive · Technische Universität Dresden · NCT06701487 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Cardiologicum Dresden und Pirna Facharztpraxis für Kardiolog · Amgen · NCT07037433 A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia Chromosome-positive Chr
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT07549516 Real-World Clinical Experience of Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Olaparib +
Phase N/A · Research Site · AstraZeneca · NCT06380738 Endometrial Cancer Lymphadenectomy Trial
NA · Universitätsklinikum Carl Gustav Carus, Klinik u. Poliklinik · Philipps University Marburg · NCT03438474 A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary
Phase N/A · Praxis Dr. Methfessel · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · NCT06686615 A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
Phase 3 · University Hospital Carl Gustav Carus · argenx · NCT06544499 A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangement
Phase 1/Phase 2 · Local Institution - 4703 · Turning Point Therapeutics, Inc. · NCT03093116 A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide
Phase 1/Phase 2 · Universitaetsklinikum Carl Gustav Carus Dresden · Celgene · NCT06988488 A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined
Phase 3 · Hematological Praxis Dresden · Regeneron Pharmaceuticals · NCT06091865 TREATgermany: German National Clinical Registry for Patients With Moderate-to-severe Atopic Dermatitis
Phase N/A · Department of Dermatology, UniversityAllergyCenter, Medical · Technische Universität Dresden · NCT03057860 A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorecta
Phase 1 · Universitätsklinik Carl Gustav Carus der Technischen Univers · Hoffmann-La Roche · NCT04929223 Visugromab in Cachexia International Trial
Phase 2/Phase 3 · University Hospital Carl Gustav Carus Dresden (Universitätsk · CatalYm GmbH · NCT07112196 DEfeating PEnile CAncer-2
NA · University Hospital Carl Gustav Carus · University Hospital Tuebingen · NCT07378670 International HIT-MED Registry (I-HIT-MED)
Phase N/A · University Hospital Dresden · Universitätsklinikum Hamburg-Eppendorf · NCT02417324 A Phase I Trial to Establish the Safety and Maximum Tolerated Dose of High-affinity Autologous BCMA-targeting Chimeric A
Phase 1 · Technische Universität Dresden, NCT/UCC, Early Clinical Tria · Technische Universität Dresden · NCT05836896 A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymph
Phase 3 · Onkologische Gemeinschaftspraxis / BAG · Loxo Oncology, Inc. · NCT05254743

Look up another city

Look up another condition